{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:11:34Z","timestamp":1789269094624,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymgme.2026.110194","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:13:50Z","timestamp":1781738030000},"page":"110194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric sleep-disordered breathing in Pompe disease in the era of enzyme replacement therapy: A retrospective cohort study"],"prefix":"10.1016","volume":"148","author":[{"given":"Vincent","family":"Lavoie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Bouchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Griffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Khirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryl","family":"Vedrenne-Cloquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Brassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Fauroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110194_bb0005","doi-asserted-by":"crossref","first-page":"1221140","DOI":"10.3389\/fped.2023.1221140","article-title":"An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion","volume":"11","author":"Colburn","year":"2023","journal-title":"Front. Pediatr."},{"issue":"15","key":"10.1016\/j.ymgme.2026.110194_bb0010","doi-asserted-by":"crossref","first-page":"15856","DOI":"10.18632\/aging.103794","article-title":"Pompe disease: pathogenesis, molecular genetics and diagnosis","volume":"12","author":"Taverna","year":"2020","journal-title":"Aging"},{"issue":"13","key":"10.1016\/j.ymgme.2026.110194_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm.2019.04.49","article-title":"An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond","volume":"7","author":"Korlimarla","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110194_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00039896.1975.10666625","article-title":"Moderate hypoxia exposure and fetal development","volume":"30","author":"Astrup","year":"1975","journal-title":"Arch. Environ. Health"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110194_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid a-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"CMM"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110194_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jimd.12560","article-title":"Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism","volume":"46","author":"Canibano-Fraile","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110194_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110194_bb0040","unstructured":"Sperry E, Leslie N, Berry L, Pena L. Pompe Disease. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1261\/."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110194_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110194_bb0050","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/ajmg.a.36227","article-title":"Polysomnographic findings in infantile Pompe disease","volume":"161","author":"Kansagra","year":"2013","journal-title":"Am. J. Med. Genetics Pt. A"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110194_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(24)00518-0","article-title":"Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe disease","volume":"24","author":"Van Der Beek","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2026.110194_bb0060","doi-asserted-by":"crossref","DOI":"10.1177\/11795565251337900","article-title":"Latest advancements in treatment options for infantile-onset Pompe disease: a comprehensive narrative review","volume":"19","author":"Khan","year":"2025","journal-title":"Clin. Med. Insights Pediatr."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110194_bb0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14656566.2025.2491508","article-title":"Improving the treatment of Pompe disease with enzyme replacement therapy: current strategies and clinical evidence","volume":"26","author":"Corsini","year":"2025","journal-title":"Expert. Opin. Pharmacother."},{"issue":"23","key":"10.1016\/j.ymgme.2026.110194_bb0070","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2200587","article-title":"In utero enzyme-replacement therapy for infantile-onset Pompe\u2019s disease","volume":"387","author":"Cohen","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110194_bb0075","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ajmg.a.37007","article-title":"Longitudinal polysomnographic findings in infantile Pompe disease","volume":"167","author":"Kansagra","year":"2015","journal-title":"Am. J. Med. Genetics Pt. A"},{"key":"10.1016\/j.ymgme.2026.110194_bb0080","series-title":"The ASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications","author":"Troster","year":"2023"},{"key":"10.1016\/j.ymgme.2026.110194_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2020.110276","article-title":"International Pediatric otolaryngology group (IPOG) consensus on the diagnosis and management of pediatric obstructive sleep apnea (OSA)","volume":"138","author":"Benedek","year":"2020","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"05","key":"10.1016\/j.ymgme.2026.110194_bb0090","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5664\/jcsm.6576","article-title":"AASM scoring manual updates for 2017 (version 2.4)","volume":"13","author":"Berry","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.ymgme.2026.110194_bb0095","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2147\/NSS.S388238","article-title":"Time under 90% oxygen saturation and systemic hypertension in patients with obstructive sleep Apnea syndrome","volume":"14","author":"Wang","year":"2022","journal-title":"NSS"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110194_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2023.03.011","article-title":"Respiratory Management of Patients with Neuromuscular Weakness","volume":"164","author":"Khan","year":"2023","journal-title":"CHEST"},{"key":"10.1016\/j.ymgme.2026.110194_bb0105","series-title":"Maladie de Pompe","author":"Protocole National de, Diagnostic et de Soins, (PNDS), Fili\u00e8res de Sant\u00e9 Maladies Rares, FILNEMUS et G2M","year":"2016"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110194_bb0110","article-title":"Clinical insight meets scientific innovation to develop a next generation ERT for Pompe disease","volume":"143","author":"Kishnani","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110194_bb0115","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1474-4422(21)00241-6","article-title":"Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial","volume":"20","author":"Diaz-Manera","year":"2021","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110194_bb0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamaneurol.2023.0552","article-title":"Efficacy and safety of Avalglucosidase alfa in patients with late-onset Pompe disease after 97 weeks: a phase 3 randomized clinical trial","volume":"80","author":"Kishnani","year":"2023","journal-title":"JAMA Neurol."},{"issue":"13","key":"10.1016\/j.ymgme.2026.110194_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.21037\/atm.2019.05.27","article-title":"Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review","volume":"7","author":"Desai","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110194_bb0130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.2005-1067","article-title":"Polysomnographic characteristics in Normal preschool and early school-aged children","volume":"117","author":"Montgomery-Downs","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.ymgme.2026.110194_bb0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.sleep.2011.05.006","article-title":"Normative values of polysomnographic parameters in childhood and adolescence: cardiorespiratory parameters","volume":"12","author":"Scholle","year":"2011","journal-title":"Sleep Med."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110194_bb0140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.sleep.2010.11.011","article-title":"Normative values of polysomnographic parameters in childhood and adolescence: quantitative sleep parameters","volume":"12","author":"Scholle","year":"2011","journal-title":"Sleep Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110194_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep Apnea: an American Academy of sleep medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.ymgme.2026.110194_bb0150","article-title":"Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease","volume":"4","author":"Desai","year":"2026","journal-title":"Genet. Med. Open"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110194_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2026.110114","article-title":"Over ten years of newborn screening for LSDs in Tuscany (Italy): epidemiology, novel variants, and the pseudodeficiency burden","volume":"148","author":"Malvagia","year":"2026","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110194_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijns12020021","article-title":"Cost-effectiveness of newborn screening for infantile-onset Pompe disease in Japan","volume":"12","author":"Konomura","year":"2026","journal-title":"Int. J. Neonatal Screen."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:11:00Z","timestamp":1784178660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1096719226004774"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110194","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric sleep-disordered breathing in Pompe disease in the era of enzyme replacement therapy: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110194"}}